Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
News Topics
- (-) Biomedical (1)
- (-) Physics (1)
- 3-D Printing/Advanced Manufacturing (1)
- Artificial Intelligence (2)
- Big Data (1)
- Biology (1)
- Buildings (1)
- Chemical Sciences (1)
- Climate Change (2)
- Computer Science (10)
- Coronavirus (1)
- Energy Storage (1)
- Environment (6)
- High-Performance Computing (6)
- Materials Science (2)
- Microscopy (1)
- Nanotechnology (1)
- Neutron Science (2)
- Nuclear Energy (1)
- Quantum Computing (1)
- Quantum Science (1)
- Security (1)
- Summit (2)
- Sustainable Energy (1)
- Transportation (1)
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Since the 1930s, scientists have been using particle accelerators to gain insights into the structure of matter and the laws of physics that govern our world.